P
Pierlanfranco D'Agaro
Researcher at University of Trieste
Publications - 74
Citations - 1492
Pierlanfranco D'Agaro is an academic researcher from University of Trieste. The author has contributed to research in topics: Population & Viral load. The author has an hindex of 22, co-authored 68 publications receiving 1162 citations.
Papers
More filters
Journal ArticleDOI
Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors.
Gianna Dal Molin,Pierlanfranco D'Agaro,Filippo Ansaldi,Giovanni Ciana,Cristina Fertz,Salvatore Alberico,Cesare Campello +6 more
TL;DR: The data show that HCV perinatal infection is a rare event and suggest that IgM positivity and high viral load in the mother are independent variables correlated with HCV transmission.
Journal ArticleDOI
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
Francesco Salton,Paola Confalonieri,G. Umberto Meduri,Pierachille Santus,Sergio Harari,Raffaele Scala,Simone Lanini,Valentina Vertui,Tiberio Oggionni,Antonella Caminati,Vincenzo Patruno,Mario Tamburrini,Alessandro Scartabellati,Mara Parati,Massimiliano Villani,Dejan Radovanovic,S. Tomassetti,Claudia Ravaglia,Venerino Poletti,Andrea Vianello,Anna Talia Gaccione,Luca Guidelli,Rita Raccanelli,Paolo Lucernoni,Donato Lacedonia,Maria Pia Foschino Barbaro,Stefano Centanni,Michele Mondoni,Matteo Davì,Alberto Fantin,Xueyuan Cao,Lucio Torelli,Antonella Zucchetto,Marcella Montico,Annalisa Casarin,Micaela Romagnoli,Stefano Gasparini,Martina Bonifazi,Pierlanfranco D'Agaro,Alessandro Marcello,Danilo Licastro,Barbara Ruaro,Maria Concetta Volpe,Reba Umberger,Marco Confalonieri +44 more
TL;DR: In patients with severe COVID-19 pneumonia, early administration of prolonged, low dose MP treatment was associated with a significantly lower hazard of death (71%) and decreased ventilator dependence and treatment was safe and did not impact viral clearance.
Journal ArticleDOI
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.
Gianna Dal Molin,Filippo Ansaldi,C. Biagi,Pierlanfranco D'Agaro,Manola Comar,Lory Saveria Crocè,Claudio Tiribelli,Cesare Campello +7 more
TL;DR: Logistic regression showed that age and injection drug use are independent determinants of genotype distribution, and subtype 1a and 3a infections were predominant in injection drug users and in community acquired infections and infections in patients with a history of transfusion.
Posted ContentDOI
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
Francesco Salton,Paola Confalonieri,Pierachille Santus,Sergio Harari,Raffaele Scala,Simone Lanini,Valentina Vertui,Tiberio Oggionni,Antonella Caminati,Vincenzo Patruno,Mario Tamburrini,Alessandro Scartabellati,Mara Parati,Massimiliano Villani,Dejan Radovanovic,Sara Tomassetti,Claudia Ravaglia,Venerino Poletti,Andrea Vianello,Anna Talia Gaccione,Luca Guidelli,Rita Raccanelli,Paolo Lucernoni,Donato Lacedonia,Maria Pia Foschino Barbaro,Stefano Centanni,Michele Mondoni,Matteo Davì,Alberto Fantin,Xueyuan Cao,Lucio Torelli,Antonella Zucchetto,Marcella Montico,Annalisa Casarin,Micaela Romagnoli,Stefano Gasparini,Martina Bonifazi,Pierlanfranco D'Agaro,Alessandro Marcello,Danilo Licastro,Barbara Ruaro,Maria Concetta Volpe,Reba Umberger,Umberto G. Meduri,Marco Confalonieri +44 more
TL;DR: In patients with severe COVID-19 pneumonia, early administration of prolonged MP treatment was associated with a significantly lower hazard of death (71%) and decreased ventilator dependence and Randomized controlled studies are needed to confirm these findings.
Journal ArticleDOI
Zika virus induces inflammasome activation in the glial cell line U87-MG
TL;DR: ZIKV is able to successfully replicate in infected cells causing oxidative stress, NLRP3 inflammasome activation and subsequent release of mature IL-1β; this process culminates in cell death.